Aw, A Success

A Forbes article entitled, “Genomics: No Longer A Failure,” says that Human Genome Sciences and Vertex Pharmaceuticals are finally living up to the hype promised during Human Genome Project. Human Genome saw positive results in a second study of its lupus drug, Benlysta, and Vertex presented mid-stage results of its hepatitis C drug, telaprevir, that indicated it could work as well if taken twice a day as three times a day, which is how it is currently being tested.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.